Mostrando 3 resultados de: 3
Filtros aplicados
Publisher
Ageing Research Reviews(1)
Biomedicine and Pharmacotherapy(1)
Experimental and Clinical Psychopharmacology(1)
Origen
scopus(3)
Real-World Clinical Characterization of Subjects With Depression Treated With Antidepressant Drugs Focused on (Non-)Genetic Factors, Pharmacokinetics, and Clinical Outcomes: GnG-PK/PD-AD Study
ArticleAbstract: This work aimed to describe and characterize the GnG-PK/PD-AD study and the population of subjects dPalabras claves:antidepressants, Cytochrome p450, P-Glycoprotein, pharmacogenetics, Real-world settingAutores:Adrián LLerena, Alves G., Falcao A.C., Fortuna A., Magalhães P.Fuentes:scopusProtein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders
ReviewAbstract: Protein tyrosine phosphatase 1B (PTP1B) is a typical member of the PTP family, considered a direct nPalabras claves:Alzheimer's disease, insulin receptor, neurodegenerative diseases, neuroinflammation, Neurological disorders, PTP1B, Type 2 DiabetesAutores:Antoni Camins, Auladell C., Bulló M., Cano A., Carrasco M., Ettcheto M., Folch J., Fortuna A., Olloquequi J., Sanchez-Lopez E., Verdaguer E.Fuentes:scopusTargeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future
ReviewAbstract: Alzheimer's disease (AD) is a well-known neurodegenerative disease characterized by the presence ofPalabras claves:Alzheimer's disease, Angiotensin, Angiotensin converting enzyme, Angiotensin II receptor blockers, Renin-angiotensin systemAutores:Antoni Camins, Bicker J., Cruz M.T., Ettcheto M., Falcao A.C., Fortuna A., Gouveia F.Fuentes:scopus